Financials Filament Health Corp.

Equities

FLHLF

CA31685W1068

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 09:52:09 2024-04-26 am EDT 5-day change 1st Jan Change
0.0344 USD -1.29% Intraday chart for Filament Health Corp. -8.75% -36.41%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 37.44 10.99 11.43 7.255 - -
Enterprise Value (EV) 1 37.44 10.99 11.43 7.255 7.255 7.255
P/E ratio -4.73 x -0.85 x - - - -
Yield - - - - - -
Capitalization / Revenue - 40.8 x 7.28 x 3.7 x 2.79 x 0.44 x
EV / Revenue - 40.8 x 7.28 x 3.7 x 2.79 x 0.44 x
EV / EBITDA - - -3.29 x -1.71 x -0.77 x 1.36 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 164,757 174,949 211,210 211,210 - -
Reference price 2 0.2272 0.0628 0.0541 0.0344 0.0344 0.0344
Announcement Date 3/31/22 3/31/23 4/2/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 0.2694 1.569 1.959 2.603 16.33
EBITDA 1 - - -3.469 -4.252 -9.38 5.34
EBIT 1 -5.822 - -3.623 -4.505 -9.649 4.76
Operating Margin - - -230.86% -229.91% -370.71% 29.15%
Earnings before Tax (EBT) -7.442 - - - - -
Net income -7.412 - - - - -
Net margin - - - - - -
EPS -0.0481 -0.0739 - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/31/22 3/31/23 4/2/24 - - -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - 0.126 0.0239 0.1256 - 0.246 1.275 0.0783 0.144 0.108 0.0252
EBITDA 1 - - - - - - -0.8448 -0.7849 -1.881 -1.38 -1.166 -1.429
EBIT 1 -1.825 - - - - - -0.8757 -0.8241 -1.943 -1.443 -1.23 -1.493
Operating Margin - - - - - - -356.03% -64.64% -2,480.98% -1,002.42% -1,138.58% -5,923.13%
Earnings before Tax (EBT) -1.929 - - - - - - - - - - -
Net income -1.899 - - - - -1.131 - - - - - -
Net margin - - - - - - - - - - - -
EPS -0.008010 -0.007750 -0.007750 -0.007480 -0.0517 -0.007430 - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 3/31/22 5/16/22 8/15/22 11/10/22 3/31/23 8/14/23 11/14/23 4/2/24 - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 0.1 - - - - -
Capex / Sales - - - - - -
Announcement Date 3/31/22 3/31/23 4/2/24 - - -
Estimates
  1. Stock Market
  2. Equities
  3. FLHLF Stock
  4. Financials Filament Health Corp.